These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 6777836

  • 1. The development of mesna for the inhibition of urotoxic side effects of cyclophosphamide, ifosfamide, and other oxazaphosphorine cytostatics.
    Brock N.
    Recent Results Cancer Res; 1980; 74():270-8. PubMed ID: 6777836
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical overview of mesna.
    Burkert H.
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():175-81. PubMed ID: 6414692
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna).
    Brock N, Pohl J, Stekar J, Scheef W.
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1377-87. PubMed ID: 6819957
    [Abstract] [Full Text] [Related]

  • 11. Identification and quantification of metabolite conjugates of activated cyclophosphamide and ifosfamide with mesna in urine by ion-pair extraction and fast atom bombardment mass spectrometry.
    Manz I, Dietrich I, Przybylski M, Niemeyer U, Pohl J, Hilgard P, Brock N.
    Biomed Mass Spectrom; 1985 Sep; 12(9):545-53. PubMed ID: 2932183
    [Abstract] [Full Text] [Related]

  • 12. [Effects of mesna (2-mercaptoethane sodium sulfonate) in children with malignant disease receiving oxazaphosphorine chemotherapy].
    Iwasaku-Fujimoto M, Fujiwara F, Todo S, Morioka Y, Imashuku S.
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):403-6. PubMed ID: 2106836
    [Abstract] [Full Text] [Related]

  • 13. [Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].
    Brock N, Stekar J.
    Arzneimittelforschung; 1982 Mar; 32(5):486-7. PubMed ID: 6809014
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Antidote against the urotoxic effects of the oxazaphorine derivatives cyclophosphamide, ifosfamide and trofosfamide].
    Brock N, Stekar J, Pohl J.
    Naturwissenschaften; 1979 Jan; 66(1):60-1. PubMed ID: 106307
    [No Abstract] [Full Text] [Related]

  • 16. Chloroacetaldehyde and its contribution to urotoxicity during treatment with cyclophosphamide or ifosfamide. An experimental study/short communication.
    Pohl J, Stekar J, Hilgard P.
    Arzneimittelforschung; 1989 Jun; 39(6):704-5. PubMed ID: 2505783
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis.
    Luce JK, Simons JA.
    Med Pediatr Oncol; 1988 Jun; 16(6):372-4. PubMed ID: 3143903
    [Abstract] [Full Text] [Related]

  • 18. The protective effect of 2-mercapto-ethane sulfonate (MESNA) on hemorrhagic cystitis induced by high-dose ifosfamide treatment tested by a randomized crossover trial.
    Sakurai M, Saijo N, Shinkai T, Eguchi K, Sasaki Y, Tamura T, Sano T, Suemasu K, Jett JR.
    Jpn J Clin Oncol; 1986 Jun; 16(2):153-6. PubMed ID: 3090314
    [Abstract] [Full Text] [Related]

  • 19. [High-dose ifosfamide therapy: systemic use of a mucolytic agent for the reduction of urotoxicity].
    Marti C, Steiner R, Viollier AF.
    Schweiz Med Wochenschr; 1979 Dec 08; 109(47):1885-7. PubMed ID: 119317
    [Abstract] [Full Text] [Related]

  • 20. Cyclophosphamide and ifosfamide: role of uroprotective agents.
    Williams SD, Munshi N, Einhorn LH, Loehrer PJ.
    Cancer Invest; 1990 Dec 08; 8(2):269. PubMed ID: 2119246
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.